baber/WOPTO huggingface dataset:
Patent CA-2508460-A1 (CA)
Inventor: STRATFORD SCOTT B
IPC: H04W88/08
Filed: 2003-10-14
Abstract: A method for transporting wireless communication signals between a centrally located base station hotel and remotely located cell sites separately digitizes RE carrier signals (440). The separately digitized downlink carriers are transmitted over a network from the base station hotel to the remote sites, remaining in digital format until they reach the terminal antenna units at the remote sites. At the antenne units, the signals are converted back to analog RIF signals and transmitted to cellular subscribers. Conversely, uplink RIF carrier signals are separately digitized at the antenna units and transported back to the base station hotel. In a preferred embodiment, the method of downlink wireless signal transport is implemented in a system comprising a base station hotel, at least one remote site, and a digital data network connecting the hotel to the remote site.
Patent CA-2510169-A1 (CA)
Title: Composes de n-(indolethyl-)cycloamine
Inventor: SEYFRIED CHRISTOPH
IPC: C07D209/42
Filed: 2003-11-27
Abstract: L'invention concerne des composés de N-(indoléthyl-)cycloamine de formule (I), dans laquelle R?1'¿, R?1 ¿ X, Ar, et n ont la signification indiquée dans la revendication 1. Ces composés constituent des inhibiteurs de la recapture de la sérotonine (SSRI) ainsi que des effecteurs des récepteurs sérotoninergiques 5-HT¿1A? et 5-HT¿2A?. Ils sont par conséquent appropriés pour la prophylaxie ou le traitement de différentes maladies du système nerveux central, telles que la dépression, la dyskinésie, la maladie de Parkinson, la démence, l'accident vasculaire cérébral, la schizophrénie, la maladie d'Alzheimer, la démence à corps de Lewy, la maladie de Huntington, le syndrome de Gilles de la Tourette, l'angoisse, les troubles de l'apprentissage et de la mémoire, la douleur, les insomnies, ainsi que les maladies neurodégénératives.
Patent CA-2510475-A1 (CA)
Title: Methode de production d'aminoacides dans des plantes transgeniques comprenant l'expression d'un acide nucleique codant une proteine de decomposition de la threonine
Inventor: SCHMITZ OLIVER
IPC: C12N9/10
Filed: 2003-12-19
Abstract: L'invention concerne un procédé de production d'aminoacides dans des organismes transgéniques, caractérisé en ce qu'il comprend les étapes suivantes : a) introduction d'une séquence d'acides nucléiques, qui code une protéine décomposant la thréonine ou une protéine décomposant la lysine ou qui code une protéine décomposant la thréonine et une protéine décomposant la lysine ; ou b) introduction d'une séquence d'acides nucléiques qui améliore la décomposition de la thréonine ou de la lysine ou la décomposition de la thréonine et de la lysine dans les organismes transgéniques ; c) expression d'une séquence d'acides nucléiques (a) ou (b) dans un organisme transgénique. De manière avantageuse, on introduit une séquence d'acides nucléiques dans l'étape a) du procédé, cette dernière étant choisie parmi : i) une séquence d'acides nucléiques avec la séquence représentée dans SEQ ID NO: 1, SEQ ID NO: 11, SEQ ID NO: 13, SEQ ID NO: 15, SEQ ID NO: 17, SEQ ID NO: 19, SEQ ID NO: 21, SEQ ID NO: 23 et/ou SEQ ID NO: 25 ; ii) une séquence d'acides nucléiques, qui est conservée en raison du code génétique dégénéré par retranscription de la séquence d'aminoacides représentée dans SEQ ID NO: 2, SEQ ID NO: 12, SEQ ID NO: 14, SEQ ID NO: 16, SEQ ID NO: 18, SEQ ID NO: 20, SEQ ID NO: 22, SEQ ID NO: 24 et/ou SEQ ID NO: 26 ; et iii) un dérivé de la séquence d'acides nucléiques représentée dans SEQ ID NO: 1, SEQ ID NO: 11, SEQ ID NO: 13, SEQ ID NO: 15, SEQ ID NO: 17, SEQ ID NO: 19, SEQ ID NO: 21, SEQ ID NO: 23 et/ou SEQ ID NO: 25, qui code les polypeptides avec la séquence d'acides nucléiques représentée dans SEQ ID NO: 2, SEQ ID NO: 12, SEQ ID NO: 14, SEQ ID NO: 16, SEQ ID NO: 18, SEQ ID NO: 20, SEQ ID NO: 22, SEQ ID NO: 24 et/ou SEQ ID NO: 26 et présente au moins 50 % d'homologie sur le plan des aminoacides, sans que l'activité biologique des polypeptides soit réduite.
Patent CA-2511975-A1 (CA)
Inventor: LIN WAYZEN
IPC: H04L29/06
Filed: 2003-12-09
Abstract: A legacy device bridge for use in a network, such as a wired or wireless residential network, is provided. The legacy device bridge performs protocol conversion to enable a network-attached entity that uses a packet-based communication protocol to communicate with and control legacy devices, such as consumer electronics, that rely exclusively on infrared (IR) or serial communication protocols. The legacy device bridge also performs a virtualization function that allows legacy devices to be advertised to the network as devices that comply with a packet-based discovery and control protocol, and to be controlled as such. The legacy device bridge is also adapted to probe, deduce and publish information relating to the state of a legacy device to other entities on the network.
Patent CA-2513368-A1 (CA)
Inventor: FOUTRAKIS GEORGE N
IPC: A61M25/10
Filed: 2004-01-14
Abstract: L'invention concerne un dispositif à cathéter qui comprend un canal pour fil-guide amovible. Ledit canal fil-guide est configuré de manière à faciliter la détection nécessaire du cathéter le long du fil-guide, lors de l'introduction du cathéter sur un site de traitement. Une fois que le traitement est terminé, le canal pour fil-guide peut être retiré, de façon à libérer le fil-guide du cathéter in situ. L'appareil de l'invention offre des avantages distincts par rapport aux procédés existants d'introduction du cathéter à échange rapide et sur le fil, comprenant la capacité à réaliser plus rapidement les échanges d'équipement du traitement, la capacité à distribuer des équipements de traitement multiples en série, et la capacité à maintenir les équipements de traitement multiples simultanément sur le site de traitement au moyen d'un fil-guide simple.
Patent CA-2513745-A1 (CA)
Title: Station de ravitaillement en hydrogene transportable
Inventor: NIEDZWIECKI ALAN
IPC: B60P3/24
Filed: 2004-01-21
Abstract: La présente invention concerne une station de ravitaillement en hydrogène portable qui peut distribuer de l'hydrogène gazeux provenant d'un ou de plusieurs réservoirs internes sous haute pression. Cette station de ravitaillement peut être remplie avec une charge d'alimentation en hydrogène gazeux à basse pression, qui peut ensuite être comprimée à l'intérieur de la station de ravitaillement en vue d'un stockage.
Patent CA-2513916-A1 (CA)
Inventor: BREUER FRANK
IPC: H01L39/16
Filed: 2005-07-27
Abstract: A resistive current limiter with at least one tubular high temperature superconductor body is disclosed provided with a shunt of a normal conducting material wound in coil configuration around the surface of the tubular superconductor body.
Patent CA-2514434-A1 (CA)
Inventor: JOHNSTON RENEE
IPC: H04B3/23
Filed: 2005-08-03
Abstract: A method is set forth for calculating an expected Echo Return Loss Enhancement (ERLE) in an echo canceller. The expected ERLE is used to control the adaptation step of an adaptive filter in the echo canceller. Also, a novel echo canceller is set forth where the adaptation step of its adaptive filter is controlled based on the expected ERLE.
Patent CA-2516433-A1 (CA)
Title: Ramosetron hydrochloride for diarrhea-predominant irritable bowel syndrome
Inventor: ATSUTA YUTAKA
IPC: C07D403/06
Filed: 2005-01-27
Abstract: A pharmaceutical composition for therapy of diarrhea irritable bowel syndrome in male and female patients, containing from 0.001 to 0.05 mg of ramosetron hydrochloride as a daily dose or an equivalent molar amount of ramosetron or its pharmaceutically acceptable other salt as an active ingredient.
Patent CA-2519504-A1 (CA)
Title: Combination assay for alcohol and drugs of abuse
Inventor: WONG RAPHAEL
IPC: G01N33/94
Filed: 2005-07-08
Abstract: A test apparatus 10 that allows testing for the presence of both drugs of abuse and alcohol within a single device. In general, the apparatus 10 of the present invention includes a lateral flow immunoassay screening for various drugs of abuse and a reactive pad 46 including an enzyme as a test for alcohol. The two types of tests are contained within the same housing 18 and these tests are performed using the same sample source 16 from a subject being tested.
Patent CA-2519605-A1 (CA)
Title: Discharge lamp lighting control device
Inventor: LEE FRED C
IPC: H02M1/42
Filed: 2004-04-22
Abstract: A discharge lamp lighting control device (100) having a DC power converter, a power factor improving power converter (1), a polarity reversing circuit (2), a starter circuit (3), and a controller (4). The power factor improving power converter 1 includes a switching device S, a power factor improver, and a power converter. The power factor improver operates to smooth a rectified voltage by storing energy in a first inductive device L1 and by discharging energy from a second inductive device L2, in which the first and second inductive devices are magnetically coupled together. The storing and discharging is performed by turning ON and OFF the switching device S. A  predetermined DC voltage is converted by energy stored and discharged by a third inductive device L3 in response to the turning ON and OFF of the switching device S.
Patent CA-2520294-A1 (CA)
Title: Device for cleaning inter-dental spaces
Inventor: LESAGE PATRICK
IPC: A61C15/00
Filed: 2004-04-06
Abstract: A device for cleaning interdental spaces has a tubular guide element having a first profiled open end to allow its positioning at the entry to an interdental space. A cleaning member mounted movably in the tubular guide element, fixed to a first end of a support member, the support member having a fixed longitudinal direction relative to the axis of the tubular guide element. A gripping member is provided for moving the cleaning member between a first position, in which they are entirely arranged inside the tubular element, and a second position, in which they are arranged entirely outside the first end of the tubular element.
Patent CA-2522791-A1 (CA)
Inventor: RVACHEV MARAT
IPC: A61J7/02
Filed: 2005-10-20
Abstract: A container for dry particulate material, such as tablets or pills, beans, cereals, coffee, sugar, fish food, fertilizer, bleach powder etc, which, when it is turned upside down, dispenses a customer defined volume amount of material, or a predefined number of pills (e.g., one pill at a time).
Patent CA-2523375-A1 (CA)
Title: Ameliorations portant sur des cartes de voeux
Inventor: SILAPROM LAAONG
IPC: B42D15/04
Filed: 2003-05-20
Abstract: L'invention porte sur une carte de voeux (1) comportant une carte postale de réponse détachable (3).
Patent CA-2531436-A1 (CA)
Title: Anion emission and anti-dust nose mask
Inventor: KIM YUNG HO
IPC: A62B18/02
Filed: 2004-07-01
Abstract: The present invention relates to an anion emission and anti-dust noise mask capable of enhancing a compatibility so that it is well adapted to various sizes and types of nose based on its flexibility, and it is possible to wear without any string based on a pressure of a mask wing part, and the mask is not slid along a nose using a magnet, and a certain mineral material capable of emitting silver, tourmaline, etc. is added to a nose mask, thus achieving an anti-bacteria, deodorizing effect, and anion generation effect by the added material.
Patent CA-2536970-A1 (CA)
Title: Crab traps
Inventor: DECEMBER JOHN
IPC: A01K69/08
Filed: 2006-02-20
Abstract: A crab trap has a mesh extending over a crab trap frame, with at least one crab inlet opening provided with a one-way inlet gate spaced apart pins which are pivotable between open and closed positions. Pin retainers prevent spreading of the pins apart from one another when the pins are in the closed position and an undersized crab outlet opening, dimensione d to allow undersized crabs to escape from the interior chamber, is provided at a side of the trap and at the bottom of the trap. The frame includes an top peripheral frame portion and t he mesh provides finger grip openings at the top peripheral frame portion. The one-way inlet gate has first and second sets of spaced apart pins, each set being pivotable independently of the other between open and closed positions. Also, the one-way inlet gate has pairs of pins which are pivotable between the open and closed positions, each pair being formed by parallel le gs of a U-shaped length of wire, with retainers engaging the legs of each pair to prevent spreading of the legs.
Patent CA-2537938-A1 (CA)
Title: Improving post-thaw survival of cryopreserved biological material by hydrostatic pressure challenge
Inventor: PRIBENSZKY CSABA
IPC: A01N1/02
Filed: 2004-09-08
Abstract: The present invention relates to a method for improving post-thaw survival of cryopreserved biological material comprising applying hydrostatic pressure to said biological material; keeping the said biological material at the hydrostatic pressure for a predetermined time period; releasing the hydrostatic pressure; and freezing the said biological material using any protocol applicable thereto. The invention also relates to the use of a pressurizing device for the pretreatment of a biological material that is to be cryopreserved, as well as to a pressurizing device for the pretreatment of a biological material that is to be cryopreserved, said device comprising a pressure chamber for receiving biological material, means to produce said pressure, and means to maintain said pressure in said chamber.
Patent CA-2538635-A1 (CA)
Inventor: BARRERAS FRANCISCO J
IPC: C02F1/30
Filed: 2006-03-02
Abstract: The method for marine sewage treatment comprises the steps of (a) dispensing with each toilet flush a controlled amount of heterotrophic bacteria culture into the boat's holding tank in order to substantially denitrify the sewage and liquefy the solids, (b) pumping raw sewage from said holding tank to fill a radiation loop, (c) applying microwave energy for a predetermined duration to the raw sewage contained within said radiation loop in order to disinfect said sewage, and (d) passing the disinfected hot sewage through a phosphate filter to substantially reduce the phosphate level. The marine sewage treatment system comprises: a toilet, a connection from a water source to said toilet, a connection from a dispenser of heterotrophic bacteria culture to said toilet, a holding tank for toilet sewage having an inlet coupled to said toilet, a macerator pump having an inlet coupled to the outlet of said holding tank and an outlet coupled to the inlet of a radiation loop, a phosphate filter having an inlet connected to the outlet of said radiation loop, an effluent discharge pump having an inlet coupled to the outlet of the phosphate filter and an outlet coupled to an effluent discharge opening to the sea and structure for applying microwave energy to said radiation loop to substantially disinfect and heat the waste water effluent in said radiation loop before filtering out the phosphates and discharging the treated effluent into the sea.
Patent CA-2540054-A1 (CA)
Title: Fatigue resistant rotary shouldered connection and method
Inventor: MURADOV ANDREI
IPC: E21B17/042
Filed: 2006-03-17
Abstract: Threaded connections are provided with a thread form that permits the construction of enlarged root radii between adjacent threads. Relatively coarse thread leads formed along conical surfaces with relatively extended tapers cooperate with relatively tall thread heights and an enlarged root radius (or radii) to produce a fatigue resistant, rotary-shouldered connection that can be assembled with reasonably attainable high torque forces. The ratios between the thread lead, measured in threads per inch, as the numerator, and denominators comprising the untruncated thread height of the thread, and/or the root truncation and/or the root radius (or radii) are maintained at low values compared to those existing in conventional prior art connections. The ratio of the untruncated thread height to the root radius (or radii) is also retained at a relatively low value as compared to that existing in many prior art configurations. The connection design produces an unexpectedly high resistance to fatigue damage or failure. The connection may he employed in any rotary-shouldered connection and is particularly effective in preventing fatigue damage in the stiffer components of drill stem assemblies including single shoulder and double shoulder drill collar connections.
Patent CA-2540817-A1 (CA)
Title: Diazabicyclononene and tetrahydropyridine derivatives as renin inhibitors
Inventor: FISCHLI WALTER
IPC: A61K31/4995
Filed: 2004-10-18
Abstract: The invention relates to novel bicyclic derivatives and related compounds and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and especially their use as inhibitors of renin.
Patent CA-2541229-A1 (CA)
Inventor: TOLAN JEFFREY S
IPC: D21H11/20
Filed: 2006-03-29
Abstract: A method of producing a hardwood pulp by mechanical refining is provided. This method comprises mechanically refining hardwood chips to produce a hardwood mechanical pulp and treating the hardwood mechanical pulp with one or more than one Family 11 xylanase at an amount effective to release a quantity of xylose from the pulp between about 0.5 to about 5.0 kg xylose/t of pulp. The enzyme-treated mechanical pulp is then further mechanically refined with a reduced demand for refining energy.
Patent CA-2543761-A1 (CA)
Inventor: SHEORY OHAD
IPC: G06F11/30
Filed: 2004-10-27
Abstract: A method and system for determining whether a client is attempting to copy an application or use the application without authorization. First, data for at least one prediction log file for the application is created. Then, based on the at least one prediction log file, prediction knowledge is determined for the application, where the prediction knowledge is stored in a prediction file. The prediction file is then forwarded to the client executing the application. It is then determined by using the predication file whether the client is attempting to copy the application or use the application without authorization. If the client is attempting to copy the application or use the application without authorization, then the client~s access to the application is terminated. In an offline mode, usage information is bound to user saved data such that modification of usage information renders user saved data unusable. This prevents unauthorized access to an offline delivered application.
Patent CA-2544745-A1 (CA)
Title: Inhalateur de poudre
Inventor: WACHTEL HERBERT
IPC: A61M16/00
Filed: 2004-11-05
Abstract: Inhalateur pour l'inhalation de médicaments sous forme de poudre se trouvant dans des capsules introduites avant l'utilisation dans un support (3) de capsule placé dans l'inhalateur. Une fois la capsule placée dans le support de capsule, le patient peut appuyer sur un organe d'actionnement (8) qui peut être mis en mouvement à partir d'une position de repos et qui coopère alors avec au moins une aiguille (9) pouvant être poussée dans le support de capsule. Les inhalateurs de ce type doivent être encore améliorés concernant le confort d'utilisation. A cet effet, dans un mode de réalisation, la présente invention concerne un inhalateur dans lequel l'organe d'actionnement est conçu sous forme d'organe d'actionnement polyvalent (8a) à l'aide duquel, dans une première position fonctionnelle, l'élément de fermeture (6) peut être désencliqueté de la partie inférieure (1) en vue du basculement du couvercle (5) et à l'aide duquel, dans une seconde position fonctionnelle, l'embout buccal (4) encliqueté avec la plaque (2) peut être libéré de ladite plaque de manière telle que l'embout buccal peut être éloigné de la partie inférieure par basculement.
Patent CA-2546493-A1 (CA)
Title: Indazole compounds and methods of use thereof as protein kinase inhibitors
Inventor: SAKATA STEVEN T
IPC: C07D403/14
Filed: 2004-11-19
Abstract: This invention is directed to Indazole Compounds or pharmaceutically acceptable salts, solvates and hydrates thereof. The Indazole Compounds have utility in the treatment or prevention of a wide range of diseases and disorders that are responsive to the inhibition, modulation or regulation of kinases, such as inflammatory diseases, abnormal angiogenesis and diseases related thereto, cancer, atherosclerosis, a cardiovascular disease, a renal disease, an autoimmune condition, macular degeneration, disease-related wasting, an asbestos-related condition, pulmonary hypertension, diabetes, obesity, pain and others. Thus, methods of treating or preventing such diseases and disorders are also disclosed, as are pharmaceutical compositions comprising one or more of the Indazole Compounds. This invention is based, in part, upon the discovery of a novel class of 5-triazolyl substituted indazole molecules that have potent activity with respect to the modulation of protein kinases. Thus, the invention encompasses orally active molecules as well as parenterally active molecules which can be used at lower doses or serum concentrations for treating diseses or disorders associated with protein kinase signal transduction.
Patent CA-2549317-A1 (CA)
Title: Pipe fitting with composite gasket assembly
Inventor: SMITH JEFFREY M
IPC: F16L21/03
Filed: 2003-12-04
Abstract: A pipe fitting (10) includes a body (12) having sockets (14) for receiving pipes (52) therein and a composite gasket (18) housed within a circumferential gasket retention housing (16) integral with the socket (14). The composite gaskets (18) include a V-shaped carrier (20) of relatively stiff plastic having an elastomeric seal portion (32) bonded thereto.
Patent CA-2549979-A1 (CA)
Inventor: LI TAO
IPC: A61P25/00
Filed: 2004-12-10
Abstract: Compounds of formula (I) or (II) , or pharmaceutically acceptable salts, esters, amides, or prodrugs thereof, wherein: A and G are each independently N  or N+-O-; m and n are each independently 0, 1, or 2; X1 and X3 are each independently O, S, and -N(R1)-; X2 is O, S, -N(R1)-, -N(Ar2)-, and -N(R2)C(O)-; Ar1 is a six-membered aromatic ring; Ar2 is cyclohexyl or a mono- or bicyclic aromatic ring, and R13 is hydrogen, alkyl, or halogen, as defined herein. The compounds are useful in treating conditions or disorders prevented by or ameliorated by nAChR ligands. Also disclosed are pharmaceutical compositions having compounds of formulas (I) and (II) and methods for using such compounds and compositions.
Patent CA-2551483-A1 (CA)
Inventor: BARBASTATHIS GEORGE
IPC: G11B7/1275
Filed: 2004-12-30
Abstract: An apparatus for replicating holographically recorded data, comprising a holographic master media (10) having holographically recorded data thereon; a holographic copy media (11); a light source for generating a master reference beam (15,16) and a copy reference beam (17, 18), coherent with the first object beam (19), the first master reference beam (15, 16) incident on the holographic master media (10), the holographic master media (10) diffracting the master reference beam (15, 16) to provide a first object beam (19); the copy reference beam (17, 18) incident on the holographic copy media (11); and a first optical relay system (12), disposed between the holographic master media (10) and the holographic copy media (10), for relaying the first object beam (19) from the holographic master media (10) to the holographic copy media (11), the holographic copy media (11) recording an interference pattern between the first object beam (19) and the copy reference beam (17, 18), thereby replicating at least a portion of holographically recorded data.